These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8641632)

  • 1. Chemotherapy treatment of chyloperitoneum and peritoneal carcinomatosis due to cervical cancer--review of literature.
    Keung YK; Whitehead RP; Cobos E
    Gynecol Oncol; 1996 Jun; 61(3):448-50. PubMed ID: 8641632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of peritoneal carcinomatosis from colorectal and appendiceal cancer by extensive cytoreductive surgery combined with hyperthermic intraoperative intraperitoneal chemotherapy].
    Legendre H; Delaunoit T; Chassaing C; Pector JC
    Rev Med Brux; 2005; 26(5):439-44. PubMed ID: 16318097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combined cytoreductive surgery and intraoperative hyperthermic chemo-perfusion for peritoneal carcinomatosis: methods, postoperative features and end results].
    Tarasov VA; Vinogradova MV; Norbaev ShE; Sharov IuK; Stavrovietskiĭ VV; Adueva SA; Blium MB
    Vopr Onkol; 2006; 52(6):638-42. PubMed ID: 17338240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Collateral effects of intraoperative hyperthermic chemotherapy in peritoneal carcinomatosis].
    Izzo L; Galati G; D'Aprile MR; Stasolla A; Kharrub Z; Maccioni F; Sassayannis PG; D'Arielli D; Marini M; Gazzanelli S; Caputo M
    G Chir; 2004; 25(1-2):43-6. PubMed ID: 15112761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale for hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment or prevention of peritoneal carcinomatosis.
    Detroz B; Laurent S; Honoré P; Blaffart F; Limet R; Meurisse M
    Acta Chir Belg; 2004 Aug; 104(4):377-83. PubMed ID: 15469146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study.
    Glehen O; Kwiatkowski F; Sugarbaker PH; Elias D; Levine EA; De Simone M; Barone R; Yonemura Y; Cavaliere F; Quenet F; Gutman M; Tentes AA; Lorimier G; Bernard JL; Bereder JM; Porcheron J; Gomez-Portilla A; Shen P; Deraco M; Rat P
    J Clin Oncol; 2004 Aug; 22(16):3284-92. PubMed ID: 15310771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IHPC): postoperative morbidity and mortality and short-term follow-up].
    Minicozzi A; Borzellino G; Momo EN; Segattini C; Pitoni F; Steccanella F; De Manzoni G
    Ann Ital Chir; 2008; 79(4):231-9. PubMed ID: 19093624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritoneal carcinomatosis: what can we do about it?
    Shen P; Levine EA; Loggie BW
    J Clin Oncol; 2004 Jan; 22(1):202; author reply 203. PubMed ID: 14701786
    [No Abstract]   [Full Text] [Related]  

  • 9. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.
    Verwaal VJ; van Ruth S; de Bree E; van Sloothen GW; van Tinteren H; Boot H; Zoetmulder FA
    J Clin Oncol; 2003 Oct; 21(20):3737-43. PubMed ID: 14551293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of peritoneal carcinomatosis of non-gynecological origin].
    Bagnenko SF; Rukhliada NV; Grinev MV; Beliaev AM
    Vestn Khir Im I I Grek; 2002; 161(6):94-9. PubMed ID: 12638508
    [No Abstract]   [Full Text] [Related]  

  • 11. [Selection criteria for peritonectomy with hyperthermic intraoperative chemotherapy (HIPEC) in peritoneal carcinomatosis].
    Königsrainer I; Aschoff P; Zieker D; Beckert S; Glatzle J; Pfannenberg C; Miller S; Hartmann JT; Schroeder TH; Brücher BL; Königsrainer A
    Zentralbl Chir; 2008 Sep; 133(5):468-72. PubMed ID: 18924046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritonectomy and hyperthermic antiblastic perfusion in the treatment of peritoneal carcinomatosis.
    Cavaliere F; Di Filippo F; Botti C; Cosimelli M; Giannarelli D; Aloe L; Arcuri E; Aromatario C; Consolo S; Callopoli A; Laurenzi L; Tedesco M; Di Angelo P; Giunta S; Cavaliere R
    Eur J Surg Oncol; 2000 Aug; 26(5):486-91. PubMed ID: 11016471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of peritoneal carcinomatosis from colorectal cancer by cytoreductive surgery and hyperthermic perioperative intraperitoneal chemotherapy.
    Kecmanovic DM; Pavlov MJ; Ceranic MS; Sepetkovski AV; Kovacevic PA; Stamenkovic AB
    Eur J Surg Oncol; 2005 Mar; 31(2):147-52. PubMed ID: 15698730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of peritoneal carcinomatosis from colorectal cancer: impact of complete cytoreductive surgery and difficulties in conducting randomized trials.
    Elias D; Delperro JR; Sideris L; Benhamou E; Pocard M; Baton O; Giovannini M; Lasser P
    Ann Surg Oncol; 2004 May; 11(5):518-21. PubMed ID: 15123461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of gastric resections during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis.
    Piso P; Slowik P; Popp F; Dahlke MH; Glockzin G; Schlitt HJ
    Ann Surg Oncol; 2009 Aug; 16(8):2188-94. PubMed ID: 19408049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status of chemotherapy in gynecologic cancer.
    Tropé C; Kristensen G
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-1-S15-22. PubMed ID: 9346216
    [No Abstract]   [Full Text] [Related]  

  • 17. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.
    Verwaal VJ; Bruin S; Boot H; van Slooten G; van Tinteren H
    Ann Surg Oncol; 2008 Sep; 15(9):2426-32. PubMed ID: 18521686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative infections in cytoreductive surgery with hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis.
    Capone A; Valle M; Proietti F; Federici O; Garofalo A; Petrosillo N
    J Surg Oncol; 2007 Nov; 96(6):507-13. PubMed ID: 17708508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Complications and tolerance of heated intraperitoneal chemotherapy and cytoreductive surgery for peritoneal carcinomatosis: results of a phase I-II study of peritoneal carcinomatosis from different sources].
    Antoun S; Meshaka P; Soltani D; Blot F; Ducreux M; Lasser P; Nitenberg G; Elias D
    Bull Cancer; 2000 Sep; 87(9):665-70. PubMed ID: 11038416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraperitoneal chemohyperthermia and attempted cytoreductive surgery in patients with peritoneal carcinomatosis of colorectal origin.
    Glehen O; Cotte E; Schreiber V; Sayag-Beaujard AC; Vignal J; Gilly FN
    Br J Surg; 2004 Jun; 91(6):747-54. PubMed ID: 15164446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.